Phibro Animal Health (PAHC) Net Cash Flow (2013 - 2026)

Phibro Animal Health's Net Cash Flow history runs 14 years deep, the most recent figure standing at -$2.9 million for Q1 2026.

• In Q1 2026, Net Cash Flow rose 60.38% year-over-year to -$2.9 million; the TTM figure through Mar 2026 stood at -$8.6 million (down 165.27% YoY), while the FY2025 annual figure was -$1.4 million, down 104.38% from the prior year.
• Net Cash Flow was -$2.9 million for Q1 2026 at Phibro Animal Health, up from -$16.8 million in the prior quarter.
• In the past five years, Net Cash Flow ranged from a high of $21.1 million in Q2 2024 to a low of -$31.2 million in Q1 2023.
• Historically, Net Cash Flow has averaged -$396000.0 across 5 years, with a median of $2.5 million in 2022.
• The sharpest annual moves came in 2022 and 2024: Net Cash Flow surged 755.51% in 2022, then plunged 1010.17% in 2024.
• A 5-year view of Net Cash Flow shows it stood at -$8.6 million in 2022, then rose by 6.7% to -$8.0 million in 2023, then soared by 336.3% to $18.9 million in 2024, then plunged by 188.84% to -$16.8 million in 2025, then surged by 82.75% to -$2.9 million in 2026.
• The last three Net Cash Flow figures came in at -$2.9 million (Q1 2026), -$16.8 million (Q4 2025), and $4.6 million (Q3 2025), per Business Quant data.